eISSN 2508-3589
pISSN 2508-1926

Table. 1.

Table. 1.

Clinical characteristics of the patients

No Sex Age (years) Diagnosis Name of the surgery Onset date of red eyes (POD) Vision (logMAR) (OD/OS) IOP (mmHg) (OD/OS) Anterior chamber cell (OD/OS) ESR (mm/hour) Auricular chondritis Treatment
1 F 48 Nontoxic single thyroid nodule TT 1 -0.1/-0.1 11/9 0.5/0.5 38 Yes PO prednisolone 30 mg, fluorometholone qid, bromfenac sodium hydrate bid
2 F 48 Thyroid cancer TT with central compartment lymph node dissection 1 -0.1/0.1 16/14 0/0 28 No PO dexibuprofen 400 mg tid, fluoro-metholone qid, bromfenac sodium hydrate bid
3 M 62 Thyroid cancer Lt. lobectomy with central compartment lymph node dissection 4 0/0 16/17 0.5/0.5 50 No PO prednisolone 30 mg, fluorometho-lone qid, bromfenac sodium hydrate bid
4 F 57 Thyroid cancer Rt. nodulectomy with Lt. lobectomy c central compartment lymph node dissection 1 0/0 17/14 0/1 53 No PO prednisolone 60 mg, loteprednol etabonate qid, bromfenac sodium hydrate bid
5 F 25 Thyroid cancer Rt. lobectomy with central compartment lymph node dissection 1 0.2/0.3 16/14 0/0 71 Yes PO prednisolone 30 mg, fluorometholone qid, bromfenac sodium hydrate bid
6 F 48 Thyroid cancer Lt. lobectomy with central compartment lymph node dissection 1 0.2/0 20/19 0.5/0.5 No PO prednisolone 30 mg, of loxacin qid, loteprednol etabonate qid
7 F 46 Thyroid cancer Rt. lobectomy with central compartment lymph node dissection 3 -0.1/-0.1 16/17 0/0 15 No PO dexibuprofen 400 mg tid, levofloxacin qid, loteprednol etabonate qid, bromfenac sodium hydrate bid
8 F 58 Thyroid cancer Lt. lobectomy with central compartment lymph node dissection 1 0.2/0.2 24/21 0.5/0.5 120 Yes PO dexibuprofen 400 mg tid, fluorometholone qid, bromfenac sodium hydrate bid
9 M 51 Gallbladder adenomatosis Laparoscopic cholecystectomy 1 0/0 18/18 1/1 No Prednisolone acetate qid
10 F 34 Extrahepatic neoplasm Laparoscopic cholecystectomy 0 0/0 8/8 2/2 No Prednisolone acetate qid
11 M 54 Gallbladder stone Laparoscopic cholecystectomy 1 0/0 10/13 1/1 No Levofloxacin qid, fluorometholone qid
12 F 49 Lt. ovary cyst Laparoscopic salpingo-oophorectomy 0 0/0 7/6 0/0 61 No Levofloxacin qid, loteprednol etabonate qid, bromfenac sodium hydrate bid
13 F 57 Lt. ovary tumor Bilateral salpingo-oophorectomy 1 0/0 24/26 0/0 No Loteprednol etabonate qid
14 F 43 Lt. ovary tumor Laparoscopic salpingo-oophorectomy 1 -0.1/0 14/10 1/1 No Prednisolone acetate qid

POD = postoperative day; logMAR = logarithm of minimal angle of resolution; OD = oculus dexter; OS = oculus sinister; IOP = intraocular pressure; ESR = erythrocyte sedimentation rate; F = female; TT = total thyroidectomy; PO = per os; qid = four times a day; tid = three times a day; M = male; Lt. = left; bid = twice a day; Rt. = right.

J Retin 2022;7:16-20 https://doi.org/10.21561/jor.2022.7.1.16
© 2022 J Retin